ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Hypogonadal men with psoriasis benefit from long-term testosterone replacement therapy
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 58684" data-attributes="member: 3"><p>Andrologia. 2016 Apr;48(3):341-6. doi: 10.1111/and.12452. Epub 2015 Jul 16.</p><p></p><p>Hypogonadal men with psoriasis benefit from long-term testosterone replacement therapy - a series of 15 case reports.</p><p></p><p>Saad F1,2, Haider A3, Gooren L4.</p><p></p><p>Author information</p><p></p><p>1Global Medical Affairs Andrology, Bayer Pharma AG, Berlin, Germany.</p><p>2Gulf Medical University, Ajman, UAE.</p><p>3Private Urology Practice, Bremerhaven, Germany.</p><p>4Department of Internal Medicine, Endocrine Section, VU medical Center, Amsterdam, The Netherlands.</p><p></p><p>Abstract</p><p></p><p>Psoriasis is increasingly recognised as a skin disease with far-reaching systemic effects, associated with a high prevalence of comorbid disease such as cardiometabolic dysfunction, shifting the focus from a single organ disease confined to the skin to a systemic inflammatory condition. Chronic and systemic inflammation plays a major role in the development of these diseases, and there are striking similarities between the molecular and inflammatory pathways in psoriasis and atherosclerosis. In a single-centre, cumulative, prospective registry study of 347 hypogonadal men (total testosterone &#8804;12.1 nmol l(-1) ), fifteen men with psoriasis could be studied. Upon testosterone administration, the skin disease improved considerably. Scores on the Psoriasis Area and Severity Index and Physician Global Assessment for Psoriasis showed significant improvement for the first 24 months. Thereafter, these improvements were sustained. Upon testosterone treatment, C-reactive protein declined significantly. There were significant improvements of obesity and of lipid profiles. Adipose tissue is now regarded as a source of inflammatory factors. These preliminary results deserve to be studied in a specifically designed study to investigate the effects of testosterone on psoriasis and its associated immunopathology.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 58684, member: 3"] Andrologia. 2016 Apr;48(3):341-6. doi: 10.1111/and.12452. Epub 2015 Jul 16. Hypogonadal men with psoriasis benefit from long-term testosterone replacement therapy - a series of 15 case reports. Saad F1,2, Haider A3, Gooren L4. Author information 1Global Medical Affairs Andrology, Bayer Pharma AG, Berlin, Germany. 2Gulf Medical University, Ajman, UAE. 3Private Urology Practice, Bremerhaven, Germany. 4Department of Internal Medicine, Endocrine Section, VU medical Center, Amsterdam, The Netherlands. Abstract Psoriasis is increasingly recognised as a skin disease with far-reaching systemic effects, associated with a high prevalence of comorbid disease such as cardiometabolic dysfunction, shifting the focus from a single organ disease confined to the skin to a systemic inflammatory condition. Chronic and systemic inflammation plays a major role in the development of these diseases, and there are striking similarities between the molecular and inflammatory pathways in psoriasis and atherosclerosis. In a single-centre, cumulative, prospective registry study of 347 hypogonadal men (total testosterone ≤12.1 nmol l(-1) ), fifteen men with psoriasis could be studied. Upon testosterone administration, the skin disease improved considerably. Scores on the Psoriasis Area and Severity Index and Physician Global Assessment for Psoriasis showed significant improvement for the first 24 months. Thereafter, these improvements were sustained. Upon testosterone treatment, C-reactive protein declined significantly. There were significant improvements of obesity and of lipid profiles. Adipose tissue is now regarded as a source of inflammatory factors. These preliminary results deserve to be studied in a specifically designed study to investigate the effects of testosterone on psoriasis and its associated immunopathology. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Hypogonadal men with psoriasis benefit from long-term testosterone replacement therapy
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top